Pay in 4 interest-free payments of $5.45 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Signs your dose needs adjustment Increase dose consideration: Minimal response after 3-4 weeks at current dose, stable weight and measurements despite consistent protocol adherence, absence of any subjective improvements in energy or fasted tolerance
A Kentucky patient with any of those flags or with active gallbladder disease, severe GERD, or a history of bariatric surgery should discuss GLP-1 candidacy with a primary care or endocrinology clinician before enrolling on any telehealth platform
Wegovy (semaglutide 2.4 mg) is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for treating obesity and overweight with weight-related health conditions
Expert Tip: This site works best if you can pinch a layer of fatty tissue
US$ 24.96
US$ 20.61
US$ 25.42
US$ 25.36
US$ 28.20
US$ 21.25
US$ 25.71
US$ 24.10
US$ 24.43
US$ 27.69
